256 Newsroom — Uganda's Digital News Infrastructure
Business

Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout - Fierce Biotech

Published by FierceBiotech By James Waldron · 24 July 2026 at 12:13
Share
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout - Fierce Biotech
Image · FierceBiotech

What the report says

Sanofi has

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Guarding the Gate: Uganda’s Drive to Keep Corruption Out of Public Service RecruitmentWatchdog Uganda From Kamwokya streets to a dog empire: The rise of ‘Uncle Dogs’The Observer Farmers flock to Sanyuka TV agricultural expo for modern farming skillsNile Post MSC Links Wealth Creation to Sanitation as Emyooga Traders Clean Usafi MarketSoftPower News Trade minister Tanna pledges support for small businesses with bankable ideasNile Post Ntungamo shuts shops as residents embrace first national cleaning dayNile Post